Concepedia

Publication | Closed Access

Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.

DOI

90

Citations

2

References

1998

Year

John Zalcberg, M.J. Millward, J. Bishop, Mark J. McKeage, Alan Zimet, Guy C. Toner, Michael Friedländer, C. E. Barter, Danny Rischin, Camille Loret,
Journal of Clinical Oncology

Abstract

Compared with other active regimens used in this setting, the combination of docetaxel and cisplatin in advanced NSCLC is an active regimen with a similar toxicity profile to other combination regimens.

References

YearCitations

Page 1